Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tarsus Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
TARS
Nasdaq
8731
https://www.tarsusrx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tarsus Pharmaceuticals Inc
Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates
- May 12th, 2024 12:32 pm
Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
- May 10th, 2024 11:20 am
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
- May 9th, 2024 9:00 pm
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript
- May 9th, 2024 4:48 pm
Tarsus Pharmaceuticals Inc (TARS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...
- May 9th, 2024 7:49 am
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
- May 8th, 2024 9:40 pm
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
- May 8th, 2024 8:05 pm
Does Tarsus Pharmaceuticals (TARS) Have the Potential to Rally 38.7% as Wall Street Analysts Expect?
- May 6th, 2024 1:55 pm
Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
- May 1st, 2024 9:00 pm
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
- Apr 23rd, 2024 12:30 pm
Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%
- Apr 19th, 2024 11:35 am
Wall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know
- Apr 8th, 2024 1:55 pm
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts
- Apr 4th, 2024 3:33 pm
Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why
- Apr 1st, 2024 4:00 pm
How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91%
- Mar 6th, 2024 2:55 pm
Tarsus to Participate at Upcoming Investor Conferences
- Mar 5th, 2024 9:30 pm
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
- Mar 5th, 2024 1:30 pm
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates
- Mar 1st, 2024 7:50 pm
Tarsus Announces Pricing of $100.0 Million Public Offering
- Mar 1st, 2024 5:07 am
Tarsus Announces Proposed $100.0 Million Public Offering
- Feb 29th, 2024 9:37 pm
Scroll